TipRanks
CytoDyn (DE:296)
STUTTGART:296
Germany Market
296
CytoDyn
RESEARCH TOOLSreports

CytoDyn (296) Income Statement

0 Followers

CytoDyn Income Statement

Last quarter (Q4 2026), CytoDyn's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, CytoDyn's net income was $-9.86M. See CytoDyn’s key income statements, including revenue, expenses, profit, and income.
Income Statement
May 26May 25May 24May 23May 22
Total Revenue
$ 0.00$ -5.92M$ 0.00$ 0.00$ 266.00K
Gross Profit
$ -17.00K$ -18.00K$ -29.00K$ -175.00K$ 213.00K
Operating Expenses
$ 21.79M$ -11.34M$ 18.06M$ 40.40M$ 72.13M
Depreciation and Amortization
$ 17.00K$ 18.00K$ 29.00K$ 175.00K$ 781.00K
EBITDA
$ -21.79M$ 8.62M$ -18.03M$ -40.40M$ -194.97M
Operating Income
$ -21.81M$ 11.32M$ -18.06M$ -40.58M$ -145.40M
Other Income/Expenses
$ -20.89M$ -7.58M$ -31.78M$ -39.25M$ -65.42M
Pretax Income
$ -42.70M$ 3.75M$ -49.84M$ -79.82M$ -210.82M
Net Income
$ -42.70M$ 3.75M$ -49.84M$ -79.82M$ -210.82M
Per Share Metrics
Basic EPS
$ -0.03$ <0.01$ -0.05$ -0.10$ -0.43
Diluted EPS
$ -0.03$ <0.01$ -0.05$ -0.10$ -0.43
Weighted Average Shares Outstanding
 1.29B 1.21B 969.51M 836.53M 676.90M
Weighted Average Shares Outstanding (Diluted)
 1.29B 1.24B 969.51M 836.53M 676.90M
Currency in USD

CytoDyn Earnings and Revenue History